GlassScriptPhysician profile
Young Il Seo
NPI 1235559527
$9,414.23
in general payments reported to CMS, 2019-2025
47 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $617 · 2021: $1,713 · 2022: $2,849 · 2023: $1,568 · 2024: $1,389 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,985.53 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Nevro Corp. | $1,158.02 | 2020-2024 | Senza |
| Abbott Laboratories | $782.03 | 2019-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $701.49 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $628.38 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Pfizer INC. | $407.44 | 2021-2025 | |
| Merz Pharmaceuticals, LLC | $299.65 | 2021-2025 | Xeomin |
| Biohaven Pharmaceutical Holding Company LTD. | $291.16 | 2022 | |
| Averitas Pharma INC. | $261.60 | 2023-2025 | Qutenza |
| Lilly USA, LLC | $250.87 | 2020-2024 | Emgality |
| Boston Scientific Corporation | $241.59 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertos Medical, INC. | $222.69 | 2019-2024 | Mild Device Kit |
| Si-Bone, INC. | $192.15 | 2023 | |
| Biodelivery Sciences International, INC. | $162.65 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.87 | 2020-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Il Seo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.